Categories: CareContentFutureHardwareHealthTechLifeMedTechScienceTechnology
Health care around the globe is changing radically. The population is growing and people are getting older. Traditional infections, together with welfare diseases such as cardiovascular diseases, obesity and diabetes, are pressuring current health care systems and providers. And as a result, more people will need treatments with less available resources.

We are committed to meet these challenges together with health care providers and be part of improving patients’ lives around the globe, today and in the future. That is why we empower our customers with knowledge, technology and resources needed to set up the most efficient structures for hospital and life science institutions and save lives with improved clinical results.

We were founded in 1904 in the village of Getinge on the Swedish west coast. Today we have more than 10 000 employees and operations in over 40 countries.
Followers
2.58K
Website visits
229.4K /mo.
Mentions
276
Location: Sweden, Gothenburg
Employees: 10001+
Founded date: 1904

Mentions in press and media 276

DateTitleDescription
29.10.2024HANZA interim report January-September 2024HANZA interim report January-September 2024 Tue, Oct 29, 2024 07:30 CET Report this content HANZA reports a continued strong financial development in the third quarter, the operating margin increased to 6.7% compared to 5.7% in Q2. During t...
28.10.2024Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion systemParagonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system Mon, Oct 28, 2024 17:05 CET Report this content Paragonix Technologies, a leading organ preservation company recently acquired by Getinge, ...
18.10.2024Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earningsGOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medte...
18.10.2024Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earningsGetinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings Fri, Oct 18, 2024 08:00 CET Report this content “The order intake increased by 10.0%, of which organic grow...
09.10.2024FleetView by Getinge elevates service with connected devicesFleetView by Getinge elevates service with connected devices Wed, Oct 09, 2024 14:00 CET Report this content Building on over 15 years of experience in connected devices, Getinge now introduces FleetView. This web application represents the...
04.10.2024Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference callGetinge invites fund managers, analysts, and media to Q3 Report 2024 conference call Fri, Oct 04, 2024 08:00 CET Report this content Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference cal...
01.10.2024HANZA presents interim report October 29HANZA presents interim report October 29 Tue, Oct 01, 2024 10:41 CET Report this content HANZA will publish its interim report for the third quarter of 2024 on October 29 at 7.30 am. In connection with the report, HANZA invites investors, a...
28.09.2024Getinge's Path to Recovery: CE Certification and Strategic PartnershipsIn the world of healthcare, every second counts. Getinge, a global leader in medical technology, has recently faced hurdles that tested its resilience. The reinstatement of its CE certificate for extracorporeal life support (ECLS) consumabl...
25.09.2024Getinge’s CE certificate for ECLS consumables reinstatedGetinge’s CE certificate for ECLS consumables reinstated Wed, Sep 25, 2024 16:07 CET Report this content The notified body, TÜV SÜD, reinstates Getinge’s CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain condit...
25.09.2024HANZA’s CEO buys sharesHANZA’s CEO buys shares Wed, Sep 25, 2024 15:54 CET Report this content HANZA's CEO Erik Stenfors has purchased 8,000 shares in HANZA for an amount of SEK 417,280. The shares were traded on September 25, 2024. After the share purchases, Eri...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In